Skip to search formSkip to main contentSkip to account menu

Atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet

Known as: ATOVAQUONE 250 mg / PROGUANIL HYDROCHLORIDE 100 mg ORAL TABLET, FILM COATED [Atovaquone and Proguanil HCl], atovaquone 250 MG / proguanil HCl 100 MG Oral Tablet, ATOVAQUONE 250MG/PROGUANIL HCL 100MG TAB [VA Product] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The drug combination atovaquone–proguanil, is recommended for treatment of uncomplicated falciparum malaria in France. Despite… 
2018
2018
Background Atovaquone-proguanil is considered causal prophylaxis (inhibition of liver-stage schizonts) for Plasmodium falciparum… 
2016
2016
BACKGROUND Current guidelines recommend daily dosing of atovaquone-proguanil (AP), beginning a day before travel to endemic areas… 
2014
2014
BACKGROUND Artemisinin-based combination therapies (ACTs) are recommended for the treatment of acute uncomplicated falciparum… 
2008
2008
Atovaquone-proguanil (Malarone; GlaxoSmithKline) is now commonly used for the treatment and prophylaxis of falciparum malaria in… 
Review
2007
Review
2007
The fixed dose combination of atovaquone and proguanil hydrochloride, marketed under the trade name Malarone, is the most… 
2006
2006
BACKGROUND Previous experience with unacceptable adverse effects with mefloquine as treatment for uncomplicated Plasmodium… 
1998
1998
ABSTRACT A phase I dose-escalating safety and pharmacokinetic study evaluated an oral suspension of micronized atovaquone (m…